Industry News

Jul 01, 2013
By BioPharm International Editors
Thermo Fisher Scientific Inc., has introduced a new-generation triple quadrupole liquid chromatography-mass spectrometry (LC-MS) platform.
Jun 12, 2013
By BioPharm International Editors
ISPE study reveals quality systems of manufacturing as the leading cause of drug shortages.
Jun 11, 2013
By BioPharm International Editors
FDA cites cGMP violations of finished pharmaceuticals at the company's facilities in Marion North Carolina and Jayuya, Puerto Rico.
Jun 11, 2013
By BioPharm International Editors
EMA?s revised guideline on biosimilars containing biotechnology-derived proteins is published for public consultation.
Jun 06, 2013
By BioPharm International Editors
FDA Discovers Microbial Contamination in Compound Pharmacy Products
Jun 05, 2013
By BioPharm International Editors
Modular containment room at Belfast facility allows studies of biologics and vaccines.
Jun 05, 2013
By BioPharm International Editors
The company is cited for using unapproved visual-inspection methods for finished parenteral drugs and conducting inadequate visual inspections.
May 30, 2013
By BioPharm International Editors
Cloud-computing solutions and software enable researchers to garner insight from large, public-health datasets.
May 28, 2013
By BioPharm International Editors
Company receives notice from FDA for not fully investigating foreign particles in APIs and finished products from its facility in Ingelheim am Rhein, Germany.
May 23, 2013
By BioPharm International Editors
New design meets new process requirements.
native1_300x100
lorem ipsum